In this section you will find information products covering Finance and Investment within the biopharmaceutical market, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.

Stay up-to-date with new products added to this category »

Title	Publication Date	Price
Biobetters Major Players and Market Prospects (2nd edition)	September 2011	£355
REMS: A Standardized Approach to Risk Management	September 2010	£295
Pricing & Reimbursement in Emerging Markets Analysis of pricing mechanisms and the influence of public and private sector health insurance provision	August 2010	£2425
The Funding Landscape for Small Biopharma Ventures, 2010-2015 Trends, strategies and priorities	July 2010	£2425
Pharma's Leaking 4.4% of Revenue Annually	December 2009	£950
Business Strategy: Revenue Leakage — Pharma's $11 Billion Problem	December 2009	£2845
Life Sciences Funding 2008	December 2009	£4110
Healthcare Stakeholders in Latin America Secrets of Engagement	December 2009	£235
Business Trends: Pharmaceuticals Technology Understanding Your Life Sciences Customer, 2009 (Customer Focus) Technology	November 2009	£2145
Pharma Corporate Venture Capital (CVC): key players, new conditions and big opportunities	September 2009	£295
Investment Patterns in the Healthcare Industry- An Analysis	September 2009	£3795
Business Strategy: Western European, Healthcare Sector Spending 2008–2012 Special Update	May 2009	£6325
Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape	December 2008	£2405
Financial Markets Research: Spectrum Pharmaceuticals\' Oral Satraplatin Oral therapy to take share in second-line hormone-refractory prostate cancer market	September 2006	£1390
Financial Markets Research: Palatin Technologies\' Bremelanotide Competition and regulatory risk cloud potential	September 2006	£1390
Financial Markets Research: Sirona Dental Systems Likely struggle for impressive annual growth despite strong reputation and technology	September 2006	£1390
Financial Markets Research: ASCO Review Part IICO 2006 Annual Meeting A summary of highlights presented at the ASCO 2006 Annual Meeting	August 2006	£1390
Financial Markets Research: Renovis, Inc.\'s NXY-059 Safety profile and unmet need could drive approval	August 2006	£1390
Financial Markets Research: Santarus, Inc.\'s Zegerid Fast-acting formulation gaining momentum in GERD	August 2006	£1390
Financial Markets Research: Endo Pharmaceuticals’ Lidoderm Physician survey indicates increased use likely to fuel above-consensus sales growth	August 2006	£1390
Financial Markets Research: ASCO Review Part II A summary of highlights presented at the ASCO 2006 Annual Meeting	August 2006	£1390
UK Pharmaceutical Executive Pay Insight into Director Remuneration	January 2005	£25
UK Pharmaceutical Executive Pay - Executive Summary only Insight into Director Remuneration	January 2005	£0
Guide to Venture Capital in European Biopharma	September 2004	£410

Receive latest news